11/19
09:15 am
fblg
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
Medium
Report
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
11/14
09:15 am
fblg
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
High
Report
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
11/13
08:05 am
fblg
FibroBiologics, Inc. (NASDAQ: FBLG) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
FibroBiologics, Inc. (NASDAQ: FBLG) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/12
04:32 pm
fblg
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/12
04:20 pm
fblg
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/30
07:27 am
fblg
FibroBiologics, Inc. (NASDAQ: FBLG) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
FibroBiologics, Inc. (NASDAQ: FBLG) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $12.00 price target on the stock.
10/29
09:15 am
fblg
FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
Low
Report
FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
10/28
09:31 am
fblg
FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
Low
Report
FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
11/12/2024
04:20 pm
fblg
fibrobiologics, inc.
BEAT
Report
-2.8%
fibrobiologics, inc.
11/12
04:02 pm
fblg
Form 10-Q FibroBiologics, Inc. For: Sep 30
Low
Report
Form 10-Q FibroBiologics, Inc. For: Sep 30
10/29
04:01 pm
fblg
Form 8-K FibroBiologics, Inc. For: Oct 25
Medium
Report
Form 8-K FibroBiologics, Inc. For: Oct 25
9/24
04:02 pm
fblg
Form 8-K FibroBiologics, Inc. For: Sep 19
Medium
Report
Form 8-K FibroBiologics, Inc. For: Sep 19
8/28
04:02 pm
fblg
Form 8-K FibroBiologics, Inc. For: Aug 27
Low
Report
Form 8-K FibroBiologics, Inc. For: Aug 27
8/27
07:56 pm
fblg
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Niklas Victoria Ninon Olivia
High
Report
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Niklas Victoria Ninon Olivia
8/27
07:55 pm
fblg
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Link Matthew
High
Report
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Link Matthew
8/27
07:53 pm
fblg
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Hoffman Robert E.
High
Report
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Hoffman Robert E.
8/27
07:52 pm
fblg
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Coen Stacy Ann
High
Report
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Coen Stacy Ann
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register